Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for minimally invasive drug delivery devices
3.2.1.2 Technological advancements
3.2.1.3 Increasing prevalence of chronic diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with drug device combination products
3.2.2.2 Technical challenges in drug delivery
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Strategic outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Drug-eluting stents
5.2.1 Coronary drug-elating stents
5.2.2 Peripheral drug-eluting stents
5.3 Infusion pumps
5.3.1 Implantable infusion pumps
5.3.2 Insulin infusion pumps
5.3.3 Patient-controlled analgesia pumps
5.3.4 Ambulatory infusion pumps
5.3.5 Volumetric infusion pumps
5.3.6 Disposable infusion pumps
5.4 Photodynamic therapy
5.5 Wound care combination product
5.6 Prefilled syringes
5.6.1 Single-chamber prefilled syringes
5.6.2 Dual-chamber prefilled syringes
5.6.3 Customized prefilled syringes
5.7 Drug-eluting balloons
5.7.1 Coronary drug-eluting balloons
5.7.2 Peripheral drug-eluting balloons
5.8 Nebulizers
5.9 Inhalers
5.9.1 Drug powdered inhalers (DPIs)
5.9.2 Metered dose inhalers (MDIs)
5.9.3 Soft mist inhalers (SMIs)
5.10 Transdermal delivery systems
5.10.1 Active transdermal systems
5.10.2 Passive transdermal systems
5.11 Orthopedic combination products
5.11.1 Bone graft implants
5.11.2 Antibiotic loaded bone cement
5.12 Antimicrobial catheters
5.12.1 Urological catheters
5.12.2 Cardiovascular catheters
5.12.3 Other catheters
5.13 Other products
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Cardiovascular disorders
6.3 Diabetes
6.4 Respiratory problems
6.5 Cancer treatment
6.6 Antimicrobial application
6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals and clinics
7.3 Ambulatory surgical centers
7.4 Home care settings
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 AbbVie, Inc.
9.3 Alcon, Inc.
9.4 Bausch Health Companies Inc
9.5 Baxter International Inc.
9.6 Bayer AG
9.7 Becton, Dickinson and Company
9.8 Boston Scientific Corporation
9.9 GlaxoSmithKline plc
9.10 Johnson & Johnson
9.11 Kaleo, Inc.
9.12 Medtronic plc
9.13 Novartis AG
9.14 SINOMED
9.15 Smith & Nephew plc
9.16 Teleflex Incorporated
9.17 Teva Pharmaceutical Industries Ltd.
